Table I.
Biomarkers used in clinical practice
Biomarkers | Clinical use |
---|---|
KRAS | Identification of resistance to anti-EGFR moAB in metastatic CRC patients |
BRAF | Identification of resistance to anti-EGFR moAB in metastatic CRC patients. |
Exclusion of Lynch Syndrome | |
MSI | Identification of Lynch Syndrome |
Oncotype DX colon cancer assay | Inform treatment planning in stage II and II colorectal cancer patients |
Abbreviations: MSI = microsatellite instability.